Internal Medicine, Hematology & Oncology · Baton Rouge, LA
NPI
1629334347
Since 2012
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
7777 Hennessy Blvd Ste 6000
Baton Rouge, LA, 70808
Phone (225) 757-0343
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
697 services
Medicare patients, 2024
141
Average age 73
Drug cost, 2024
$1.1M
1,058 prescriptions
Company payments, 2025
$1,465
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sobia Ozair was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 292 times for 107 patients. In total Sobia Ozair billed 697 services in 16 codes, and Medicare paid $43K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-03.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 292 | 107 | $12.14 | $3,546 |
| 99215 Office E&M - Established | Office | 134 | 39 | $130.11 | $17K |
| 99214 Office E&M - Established | Office | 114 | 60 | $86.65 | $9,878 |
| 99213 Office E&M - Established | Office | 46 | 36 | $63.85 | $2,937 |
| 99232 Hospital E&M - Subsequent | Facility | 30 | 18 | $59.02 | $1,771 |
| 99205 Office E&M - New | Office | 16 | 16 | $163.27 | $2,612 |
| 99222 Hospital E&M - Initial | Facility | 13 | 13 | $90.36 | $1,175 |
| 99212 Office E&M - Established | Office | 11 | 11 | $28.13 | $309 |
By year: 2022 $59K for 512 services; 2023 $48K for 416 services; 2024 $43K for 697 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sobia Ozair prescribed most often to Medicare patients was Letrozole, with 109 prescriptions and refills. In total Sobia Ozair wrote 1,058 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 109 | 221 | 35 | $2,387 |
| Anastrozole Generic | 88 | 217 | 35 | $1,867 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 46 | 46 | 16 | $857 |
| Eliquis Apixaban | 38 | 54 | Under 11 | $31K |
| Gabapentin Generic | 35 | 35 | 12 | $218 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 34 | 34 | 13 | $892 |
| Prednisone Generic | 33 | 38 | 14 | $92.25 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 29 | 31 | 11 | $402 |
| Amlodipine Besylate Generic | 28 | 45 | Under 11 | $64.01 |
| Levothyroxine Sodium Generic | 27 | 41 | Under 11 | $149 |
| Oxycodone Hcl Generic | 26 | 26 | Under 11 | $394 |
| Ondansetron Odt Ondansetron | 24 | 24 | 14 | $349 |
| Promethazine Hcl Generic | 23 | 23 | 16 | $258 |
| Pantoprazole Sodium Generic | 23 | 29 | Under 11 | $233 |
| Xarelto Rivaroxaban | 19 | 19 | Under 11 | $11K |
Brand drugs: 151 claims; generic drugs: 907 claims; opioid claims: 135.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sobia Ozair $1,465 ($1,465 in general payments such as food, travel and fees) from 21 companies. The largest payer was Daiichi Sankyo Inc. with $286.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 12 | $286 |
| Gilead Sciences, Inc. GILD | 12 | $245 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $168 |
| Pfizer Inc. PFE | 9 | $145 |
| Abbvie Inc. ABBV | 5 | $105 |
| Celgene Corporation BMY | 5 | $85.13 |
| GlaxoSmithKline, LLC. GSK | 4 | $83.07 |
| Merck Sharp & Dohme LLC MRK | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $34.55 |
| Novocure Inc. NVCR | 2 | $34.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.